Selenium shows no benefit in prevention of lung cancer, study suggests

Selenium, a supplement taken daily by millions in hopes of protection against cancer and a host of other diseases, has proven to be of no benefit in reducing a patient's risk of developing lung cancer -- either a recurrence or second primary malignancy, according to results of an international Phase III clinical trial.

Read the whole article on Science Daily

More from Science Daily